List of works - David Veesler

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses

scientific article published in 2022

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

scientific article published on 12 August 2022

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

scientific article published on 19 April 2021

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

scientific article published on 30 September 2019

Broad betacoronavirus neutralization by a stem helix–specific human antibody

scientific article

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

scientific article

Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

scientific article published in 2021

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

scientific article published on 18 May 2020

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

scientific article published on 09 September 2020

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

scientific article published on 17 June 2020

Designed proteins assemble antibodies into modular nanocages

scientific article published on 01 December 2020

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

scientific article published on 31 October 2020

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

scientific article published on 12 August 2020

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

scientific article published on 27 November 2020

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core

article

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

scientific article published on 11 November 2022

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus

article

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

scientific article

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

scientific article published on 16 September 2020

Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays

scientific article published on 24 April 2020

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

scientific article

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

scientific article

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

scientific article

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

scientific article published on 01 September 2020

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

scientific article published on 09 April 2020

Structural basis for human coronavirus attachment to sialic acid receptors

scientific article published in June 2019

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation

scientific article published on 04 August 2020

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

scientific article published on 02 December 2019

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

scientific article published on 04 August 2020

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

scientific article published in 2022

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

scientific article

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

scientific article published on 21 February 2019

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

scientific article published on 01 December 2020

List of works by David Veesler

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

Designed proteins assemble antibodies into modular nanocages

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

Structural basis for human coronavirus attachment to sialic acid receptors

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion